HackensackUMC First in State to Perform New Procedure to Treat Obesity

October 7, 2016 03:46 PM
Hackensack University Medical Center, a member of Hackensack Meridian Health, is the first hospital in New Jersey to implant the vBloc® Therapy for the treatment of obesity. This FDA-approved procedure make weight-loss surgery available to people who may not have been candidates for gastric bypass and other weight loss surgeries. The procedure was performed by Hans J. Schmidt, M.D., FACS, chief, Division of Bariatric Surgery and director, Center for Bariatric Medicine and Surgery Department of Surgery at HackensackUMC. 
“More than 20 million Americans suffer from morbid obesity, making it one of the leading medical problems facing the country today,” said Dr. Schmidt. “vBloc Therapy provides patients with a bariatric surgical option they have never had before – a positive path to addressing their weight issues that does not compromise their lifestyle or social well-being.  The Center for Bariatric Medicine and Surgery at HackensackUMC is pleased to be among the first to be certified in the surgical technique for implanting the Maestro System so that our patients are able to lose weight through vBloc.”
vBloc Therapy is delivered by a pacemaker-like device that is implanted, usually in an outpatient procedure, to control both hunger and fullness by intermittently blocking the primary nerve which regulates the digestive system, the vagus nerve. vBloc Therapy does not surgically alter or restrict the digestive system, does not create barriers to prevent absorption of nutrients and is completely reversible, allowing patients to lose weight without lifestyle compromises.
“vBloc Therapy allows patients to lose weight by reducing their food intake, helping them feel less hungry and more ‘full’ for longer periods of time,” said Martin S. Karpeh, M.D., chairman, Department of Surgery at HackensackUMC.   “Unlike other weight loss treatments that alter the gastrointestinal tract, vBloc Therapy blocks impulses that alert a person when they are hungry and transmits a signal from the stomach to the brain that provides the sensation of being full.”
“I commend our surgery team, under the direction of Dr. Karpeh, for seeking the most advanced treatments for our patients,” said Ihor S. Sawczuk, M.D., president, HackensackUMC. “This new cutting-edge technology in the arena of minimally invasive weight loss procedures is another example of the commitment by our physicians and team members to offer our patients more options and innovative treatments.”
On January 14, 2015, EnteroMedics Inc. (NASDAQ: ETRM) announced that the U.S. Food and Drug Administration (FDA) approved vBloc® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in more than ten years.
The Center for Bariatric Medicine and Surgery at HackensackUMC is one of the highest volume weight loss surgery centers in the United States. Having performed the first laparoscopic gastric bypass in New Jersey in 1999, and since then has performed more than 10,000 bariatric procedures. 
HackensackUMC is an American College of Surgeons Center of Excellence, which qualifies doctors to perform all surgical options that are available.  In addition to the commonly performed laparoscopic gastric bypass, vertical sleeve gastrectomy and gastric banding, the Center for Bariatric Medicine and Surgery offers cutting-edge endoscopic and neuromodulatory procedures. The surgical program is combined with a multidisciplinary medical program to provide patients with comprehensive care before and after surgery.  By partnering with the HackensackUMC Fitness and Wellness Center, patients have a complete program to achieve their health and fitness goals.  

About Hackensack University Medical Center

HackensackUMC, a 775-bed nonprofit teaching and research hospital located in Bergen County, NJ, is the largest provider of inpatient and outpatient services in the state. Founded in 1888 as the county’s first hospital, it is a member of Hackensack Meridian Health, one of the largest networks in the state comprised of 28,000 team members and more than 6,000 physicians. HackensackUMC was listed as the number one hospital in New Jersey in U.S. News & World Report’s 2016-17 Best Hospital rankings - maintaining its place atop the NJ rankings since the rating system was introduced. It was also named one of the top four New York Metro Area hospitals. HackensackUMC is one of only five major academic medical centers in the nation to receive Healthgrades America’s 50 Best Hospitals Award for five or more years in a row. The medical center is one of the top 25 green hospitals in the country according to Practice Greenhealth, and received 24 Gold Seals of Approval™ by The Joint Commission – more than any other hospital in the country. It was the first hospital in New Jersey and second in the nation to become a Magnet® recognized hospital for nursing excellence; receiving its fifth consecutive designation in 2014. HackensackUMC has created an entire campus of award-winning care, including: the John Theurer Cancer Center; the Heart & Vascular Hospital; and the Sarkis and Siran Gabrellian Women’s and Children’s Pavilion, which houses the Joseph M. Sanzari Children’s Hospital and Donna A. Sanzari Women’s Hospital, which was designed with The Deirdre Imus Environmental Health Center and listed on the Green Guide’s list of Top 10 Green Hospitals in the U.S. HackensackUMC is the Hometown Hospital of the New York Giants and the New York Red Bulls and is Official Medical Services Provider to The Barclays PGA Golf Tournament. It remains committed to its community through fundraising and community events. To learn more, visitwww.HackensackUMC.org.




best-hospitals-cardiology    high-performing-indicator-heartfailure    high-performing-indicator-heartbypass     HG_Americas_50_Best_Award_Image_2014      HG_Americas_100_Best_Stroke_Care_Award_Image_2014        HG_Americas_100_Best_Pulmonary_Care_Award_Image_2014     red-bulllgbt      tkc_homepagelogo-2

Translation service provided by Google. Hackensack University Medical Center is not responsible for the accuracy of translation or any other aspect of service provided by the GoogleTranslate tool. Users should not make medical decisions without first consulting with their physician.

Site Map
|Privacy Policy|Media Center

©2017 Hackensack University Medical Center. All rights reserved.
close (X)